Central Trust Company’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$701K Buy
2,375
+24
+1% +$7.13K 0.01% 387
2025
Q4
$642K Sell
2,351
-96
-4% -$26.1K 0.01% 393
2025
Q3
$661K Sell
2,447
-61
-2% -$16.6K 0.01% 391
2025
Q2
$691K Sell
2,508
-3
-0.1% -$816 0.02% 375
2025
Q1
$666K Sell
2,511
-201
-7% -$49.6K 0.02% 374
2024
Q4
$630K Buy
2,712
+390
+17% +$89.7K 0.02% 381
2024
Q3
$512K Sell
2,322
-340
-13% -$70.4K 0.01% 402
2024
Q2
$523K Buy
2,662
+31
+1% +$6.41K 0.01% 399
2024
Q1
$566K Buy
2,631
+20
+0.8% +$4.2K 0.01% 403
2023
Q4
$550K Buy
2,611
+17
+0.7% +$3.63K 0.01% 402
2023
Q3
$519K Sell
2,594
-12
-0.5% -$2.38K 0.02% 401
2023
Q2
$483K Buy
2,606
+210
+9% +$38.8K 0.01% 416
2023
Q1
$459K Hold
2,396
0.01% 421
2022
Q4
$403K Sell
2,396
-50
-2% -$8.69K 0.01% 423
2022
Q3
$433K Sell
2,446
-435
-15% -$86K 0.01% 394
2022
Q2
$590K Sell
2,881
-145
-5% -$30.7K 0.02% 352
2022
Q1
$720K Sell
3,026
-40
-1% -$9.39K 0.02% 358
2021
Q4
$700K Hold
3,066
0.02% 388
2021
Q3
$593K Sell
3,066
-80
-3% -$16.2K 0.02% 395
2021
Q2
$669K Sell
3,146
-70
-2% -$14.8K 0.02% 369
2021
Q1
$657K Sell
3,216
-139
-4% -$27.4K 0.03% 356
2020
Q4
$611K Sell
3,355
-222
-6% -$37.8K 0.03% 341
2020
Q3
$598K Buy
3,577
+73
+2% +$12.3K 0.03% 317
2020
Q2
$569K Sell
3,504
-770
-18% -$138K 0.03% 313
2020
Q1
$739K Sell
4,274
-210
-5% -$41.8K 0.05% 261
2019
Q4
$900K Sell
4,484
-18
-0.4% -$3.69K 0.05% 274
2019
Q3
$951K Sell
4,502
-50
-1% -$10.4K 0.05% 252
2019
Q2
$939K Sell
4,552
-55
-1% -$10.1K 0.05% 245
2019
Q1
$758K Sell
4,607
-5,010
-52% -$886K 0.05% 269
2018
Q4
$1.81M Sell
9,617
-112
-1% -$20.7K 0.12% 156
2018
Q3
$1.66M Sell
9,729
-169
-2% -$28.5K 0.1% 187
2018
Q2
$1.62M Buy
9,898
+2,927
+42% +$478K 0.1% 180
2018
Q1
$1.13M Sell
6,971
-652
-9% -$104K 0.07% 227
2017
Q4
$1.11M Sell
7,623
-330
-4% -$47K 0.07% 232
2017
Q3
$1.08M Sell
7,953
-355
-4% -$44.8K 0.07% 225
2017
Q2
$1.04M Sell
8,308
-135
-2% -$16.1K 0.07% 229
2017
Q1
$1M Sell
8,443
-269
-3% -$32.4K 0.07% 228
2016
Q4
$1M Sell
8,712
-7,420
-46% -$826K 0.07% 223
2016
Q3
$1.69M Buy
16,132
+76
+0.5% +$7.93K 0.12% 163
2016
Q2
$1.56M Buy
16,056
+3,620
+29% +$342K 0.12% 169
2016
Q1
$1.2M Buy
12,436
+8,241
+196% +$750K 0.09% 185
2015
Q4
$380K Buy
4,195
+525
+14% +$49.4K 0.03% 317
2015
Q3
$340K Buy
3,670
+175
+5% +$16.6K 0.03% 326
2015
Q2
$325K Sell
3,495
-20
-0.6% -$1.87K 0.03% 358
2015
Q1
$333K Sell
3,515
-60
-2% -$5.56K 0.03% 348
2014
Q4
$317K Hold
3,575
0.03% 358
2014
Q3
$286K Hold
3,575
0.02% 376
2014
Q2
$254K Sell
3,575
-50
-1% -$3.52K 0.02% 399
2014
Q1
$268K Sell
3,625
-640
-15% -$48.3K 0.02% 383
2013
Q4
$335K Buy
4,265
+50
+1% +$3.92K 0.03% 357
2013
Q3
$311K Sell
4,215
-9,060
-68% -$667K 0.03% 351
2013
Q2
$1.01M Buy
+13,275
New +$871K 0.1% 187

Other funds holding CME

Central Trust Company's CME Position: Q1 2026 in Review

Central Trust Company increased its CME Group (CME) stake by 1% in Q1 2026, buying an estimated $7.13K and bringing the position to 2,375 shares worth $701K. The position accounts for 0.01% of the portfolio, ranked #387.

Central Trust Company first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.81M in Q4 2018. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Central Trust Company held 2,375 shares of CME Group worth $701K as of Q1 2026.
  • Central Trust Company bought 24 CME Group shares in Q1 2026, an estimated $7.13K.
  • CME Group made up 0.01% of Central Trust Company's portfolio in Q1 2026, its #387 holding.
  • Central Trust Company first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's CME Group position peaked at $1.81M in Q4 2018.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.